Certuity LLC bought a new position in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 2,225 shares of the company’s stock, valued at approximately $270,000.
A number of other institutional investors have also recently made changes to their positions in the stock. OFI Invest Asset Management bought a new stake in Kimberly-Clark during the third quarter valued at $25,000. Cranbrook Wealth Management LLC lifted its stake in shares of Kimberly-Clark by 90.9% in the 4th quarter. Cranbrook Wealth Management LLC now owns 210 shares of the company’s stock valued at $26,000 after purchasing an additional 100 shares during the period. Centerpoint Advisors LLC grew its stake in Kimberly-Clark by 175.0% during the third quarter. Centerpoint Advisors LLC now owns 275 shares of the company’s stock worth $33,000 after purchasing an additional 175 shares during the period. Wetzel Investment Advisors Inc. bought a new stake in Kimberly-Clark in the fourth quarter worth approximately $35,000. Finally, Legacy Financial Group LLC acquired a new position in Kimberly-Clark in the third quarter valued at approximately $37,000. Institutional investors own 76.29% of the company’s stock.
Kimberly-Clark Stock Performance
NYSE:KMB opened at $136.47 on Thursday. Kimberly-Clark Co. has a twelve month low of $116.32 and a twelve month high of $147.02. The company has a quick ratio of 0.54, a current ratio of 0.81 and a debt-to-equity ratio of 6.05. The stock has a market cap of $45.95 billion, a P/E ratio of 25.09, a PEG ratio of 3.89 and a beta of 0.38. The business’s 50-day moving average price is $126.88 and its two-hundred day moving average price is $123.24.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on KMB shares. Citigroup upped their price objective on shares of Kimberly-Clark from $111.00 to $125.00 and gave the company a “sell” rating in a report on Wednesday, April 24th. UBS Group boosted their price objective on Kimberly-Clark from $135.00 to $138.00 and gave the company a “neutral” rating in a report on Wednesday, April 24th. Barclays lifted their price target on shares of Kimberly-Clark from $132.00 to $136.00 and gave the company an “equal weight” rating in a research report on Thursday, April 25th. The Goldman Sachs Group upped their price objective on shares of Kimberly-Clark from $135.00 to $152.00 and gave the stock a “buy” rating in a report on Wednesday, April 24th. Finally, Piper Sandler lifted their price objective on shares of Kimberly-Clark from $145.00 to $152.00 and gave the company an “overweight” rating in a report on Thursday, March 28th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, Kimberly-Clark currently has a consensus rating of “Hold” and a consensus price target of $134.85.
Check Out Our Latest Stock Report on Kimberly-Clark
Insider Activity at Kimberly-Clark
In other news, insider Paula Ramos sold 10,178 shares of Kimberly-Clark stock in a transaction dated Wednesday, April 24th. The stock was sold at an average price of $137.17, for a total value of $1,396,116.26. Following the transaction, the insider now owns 795 shares in the company, valued at $109,050.15. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other Kimberly-Clark news, insider Jeffrey P. Melucci sold 6,390 shares of the stock in a transaction on Monday, April 29th. The shares were sold at an average price of $135.59, for a total transaction of $866,420.10. Following the completion of the sale, the insider now owns 33,649 shares of the company’s stock, valued at approximately $4,562,467.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Paula Ramos sold 10,178 shares of the business’s stock in a transaction dated Wednesday, April 24th. The shares were sold at an average price of $137.17, for a total transaction of $1,396,116.26. Following the completion of the transaction, the insider now owns 795 shares in the company, valued at approximately $109,050.15. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 18,062 shares of company stock valued at $2,466,270. Insiders own 0.62% of the company’s stock.
Kimberly-Clark Company Profile
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Further Reading
- Five stocks we like better than Kimberly-Clark
- Profitably Trade Stocks at 52-Week Highs
- Kraft Heinz: Serving Up A Tasty Dip for Investors to Snack On
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Yum! Brands: Can Digital Strength Offset Same-Store Declines?
- Insider Trading – What You Need to Know
- Wall Street Believes in First Solar Stock’s Bull Cycle
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Co. (NYSE:KMB – Free Report).
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.